Ardent Health, Inc. $ARDT Shares Bought by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. has significantly increased its stake in Ardent Health, Inc., holding approximately $18.30 million worth of shares after a 368.9% increase in the 1st quarter.
• Several institutional investors, including Deutsche Bank AG and Y Intercept Hong Kong Ltd, also expanded their positions in Ardent Health, reflecting growing interest in the company.
• Ardent Health's stock has received mixed evaluations from analysts, with a consensus rating of "Moderate Buy" and an average target price of $19.56, indicating potential upsides despite recent downgrades.

Vanguard Group Inc. raised its holdings in Ardent Health, Inc. (NYSE:ARDT - Free Report) by 368.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,330,635 shares of the company's stock after purchasing an additional 1,046,845 shares during the period. Vanguard Group Inc. owned about 0.93% of Ardent Health worth $18,296,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in ARDT. Point72 Asset Management L.P. grew its holdings in Ardent Health by 7.9% during the 4th quarter. Point72 Asset Management L.P. now owns 1,609,720 shares of the company's stock worth $27,494,000 after acquiring an additional 117,421 shares in the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of Ardent Health by 4.8% during the first quarter. Allspring Global Investments Holdings LLC now owns 817,182 shares of the company's stock worth $10,599,000 after purchasing an additional 37,581 shares during the period. Nuveen Asset Management LLC lifted its position in shares of Ardent Health by 220.6% in the 4th quarter. Nuveen Asset Management LLC now owns 169,475 shares of the company's stock worth $2,895,000 after buying an additional 116,610 shares during the last quarter. Bank of America Corp DE grew its position in shares of Ardent Health by 128.8% during the 4th quarter. Bank of America Corp DE now owns 168,370 shares of the company's stock valued at $2,876,000 after buying an additional 94,772 shares during the last quarter. Finally, Squarepoint Ops LLC raised its stake in Ardent Health by 1.8% during the fourth quarter. Squarepoint Ops LLC now owns 101,798 shares of the company's stock worth $1,739,000 after acquiring an additional 1,798 shares during the period.

Analysts Set New Price Targets

Several equities analysts have recently commented on ARDT shares. JPMorgan Chase & Co. lowered their target price on Ardent Health from $18.00 to $15.00 and set a "neutral" rating for the company in a report on Monday, August 11th. Stephens reaffirmed an "overweight" rating and issued a $21.00 target price on shares of Ardent Health in a research report on Tuesday, May 20th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $21.00 target price on shares of Ardent Health in a research note on Thursday, May 15th. Wall Street Zen upgraded shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Finally, Bank of America cut shares of Ardent Health from a "neutral" rating to an "underperform" rating and dropped their price objective for the stock from $15.50 to $14.60 in a report on Wednesday, July 16th. Eight investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $19.56.

Ardent Health Price Performance

ARDT traded up $0.06 on Thursday, reaching $12.85. The company had a trading volume of 178,677 shares, compared to its average volume of 315,327. The company has a market capitalization of $1.84 billion, a P/E ratio of 7.10, a PEG ratio of 5.65 and a beta of 0.30. The company has a current ratio of 2.13, a quick ratio of 2.00 and a debt-to-equity ratio of 0.66. The company has a fifty day moving average of $12.35 and a 200-day moving average of $13.19. Ardent Health, Inc. has a one year low of $10.10 and a one year high of $20.72.

Ardent Health (NYSE:ARDT - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.30 by $0.22. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, equities research analysts anticipate that Ardent Health, Inc. will post 1.23 earnings per share for the current year.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.